Michaela Ann Dinan, PhD

Assistant Professor in Population Health Sciences
Assistant Professor in Medicine
Member of the Duke Cancer Institute
Membership in the Duke Clinical Research Institute
Campus mail 2200 West Main Street Suite 720-A, Durham, NC 27705
Phone (919) 668-8177
Email address michaela.dinan@duke.edu

Dr. Dinan is a health services researcher with a focus on emerging medical technology in cancer. Dr. Dinan currently holds an AHRQ K99/R00 pathway to independence award to examine adoption of Oncotype DX molecular testing in breast cancer and has conducted work in breast and other cancers examining emerging technologies and their associated disparities in utilization, outcomes and costs. Dr. Dinan has expertise in both secondary data analysis and clinical registry methodologies. Her secondary data expertise include the SEER-Medicare linked data, Medicare claims, NIS, NCDB, as well as EHR data.

Dr. Dinan holds additional appointments at the Duke Clinical Research Institute and Duke Cancer Institute where she co-leads the Patient Experience and Survivorship Focus Area in the Cancer Control and Population Sciences Program.

Areas of expertise: Health Economics, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of North Carolina at Chapel Hill, 2011
  • B.S., University of Virginia, 2003

Publications

Dinan, MA, Curtis, LH, Setoguchi, S, and Cheung, WY. "Advanced imaging and hospice use in end-of-life cancer care." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer (May 4, 2018).

PMID
29728843
Full Text

Georgieva, M, Lund, J, Nielsen, M, Trogdon, J, Dinan, M, Weinberger, M, and Wheeler, S. "The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer." May 2018.

Full Text

Wilson, LE, Pollack, CE, Greiner, MA, and Dinan, MA. "Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011." Breast Cancer Research and Treatment (March 13, 2018).

PMID
29536319
Full Text

Dinan, MA, Georgieva, M, Shenolikar, R, and Scales, CD. "Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma." February 20, 2018.

Full Text

Dinan, MA, Wilson, LE, Greiner, M, and Pollack, CE. "Provider characteristics and receipt of oncotype Dx testing in women diagnosed with early stage breast cancer using SEER-Medicare data." San Antonio Breast Cancer Symposium. San Antonio, TX. December 5, 2017 - December 9, 2017.: AMER ASSOC CANCER RESEARCH, February 1, 2018.

Scholars@Duke

Clough, JD, Dinan, MA, and Schulman, KA. "Trends in hospital-physician integration in medical oncology." The American journal of managed care 23, no. 10 (October 2017): 624-627.

PMID
29087634
Scholars@Duke

Savla, B, Ahmed, KA, Yu, M, Perez, BA, Dinan, MA, Mason, N, and Robinson, TJ. "Use of Whole Brain Radiation Therapy and Immune Checkpoint Inhibition in the Management of Brain Metastases." October 2017.

Full Text

Harowicz, MR, Robinson, TJ, Dinan, MA, Saha, A, Marks, JR, Marcom, PK, and Mazurowski, MA. "Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset." Breast cancer research and treatment 162, no. 1 (February 2017): 1-10.

PMID
28064383
Full Text

Kim, E, Dinan, M, Islam, KMM, Fernandes, A, Schwartzberg, L, Croft, E, Brahmer, J, Mansfield, A, Hyslop, T, Burke, L, and Crawford, J. "Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress.": ELSEVIER SCIENCE INC, November 1, 2016.

Scholars@Duke

Kim, E, Dinan, M, Islam, KM, Fernandes, A, Schwartzberg, L, Croft, E, Brahmer, J, Mansfield, A, Hyslop, T, Burke, L, and Crawford, J. "PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11, no. 11S (November 2016): S308-S309.

PMID
27969528
Full Text

Pages